/EIN News/ — VANCOUVER, British Columbia, Dec. 02, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, is pleased to provide an introduction to Dr. Alexander MacGregor, a key scientific advisor to the Company.
Pure Extracts and Dr. MacGregor are collaborating on the development of CBD infused mushroom wellness products and are researching the optimum extraction methodologies for psilocybin in order to prepare the Company to enter the psychedelic mushroom extraction space.
Dr. MacGregor is the Dean of Faculty, distinguished Professor of Biopharmaceutics and current President of the Toronto Institute of Pharmaceutical Technology (TIPT®) – North America’s premier post-graduate institute of pharmaceutical sciences, technology and research. He is also the CEO of TIPT’s parent company, Transpharm Canada Inc., which has a Health Canada Drug Establishment License, a Cannabis Drug License and a Dealer’s License issued under the Controlled Drugs and Substances Act (CDSA). Transpharm Canada conducts cannabis testing, clinical trials, drug development and is licensed to possess psychedelic drug compounds.
Dr. MacGregor is recognized as a…
Original Author Link click here to read complete story..